Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer
© Van Laar; licensee BioMed Central Ltd. 2012
Received: 9 August 2011
Accepted: 2 July 2012
Published: 2 July 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|9 Aug 2011||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|1 Oct 2011||Reviewed||Reviewer Report - Ming Tsao|
|7 Oct 2011||Reviewed||Reviewer Report - Jyothi Subramanian|
|2 Dec 2011||Author responded||Author comments - Ryan Van Laar|
|Resubmission - Version 3|
|2 Dec 2011||Submitted||Manuscript version 3|
|6 Feb 2012||Reviewed||Reviewer Report - Jyothi Subramanian|
|30 Mar 2012||Reviewed||Reviewer Report - Christine Duarte|
|11 Apr 2012||Author responded||Author comments - Ryan Van Laar|
|Resubmission - Version 4|
|11 Apr 2012||Submitted||Manuscript version 4|
|2 Jul 2012||Editorially accepted|
|2 Jul 2012||Article published||10.1186/1755-8794-5-30|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.